A SURVEILLANCE STUDY OF CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - 10-YEAR FOLLOW-UP

被引:78
作者
NICOLAI, N
PIZZOCARO, G
机构
[1] Division of Urology, Istituto Nazionale Tumori, Milan
关键词
CARCINOMA; TESTICULAR NEOPLASMS; SURVIVAL; NEOPLASM METASTASIS;
D O I
10.1016/S0022-5347(01)66972-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We evaluate the 10-year results of a surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis. Materials and Methods: Between 1981 and 1984 we recruited 85 consecutive evaluable patients with nonseminomatous germ cell tumors of the testis and normal post-orchiectomy physical examination, chest x-rays, bipedal lymphangiography, abdominal scans and serum tumor markers. The patients were followed for at least 10 years after orchiectomy alone, which was performed elsewhere in 90% of the cases. Results. The interval between visits was twice as long as it was scheduled. Relapses occurred in 25 patients (29.4%) after a median disease-free interval of 7 months (range 2 to 68). Five patients had further relapses and 3 (3.5%) died of cancer. Retroperitoneal relapses (19%) occurred later than lung relapses, and they were diagnosed when larger than 5 cm. in 7 patients. The percentage of embryonal carcinoma within the tumor associated with relapse (p = 0.008), T category (p = 0.023), scrotal violation (p = 0.042) and vascular invasion (p = 0.063) had a weak correlation but data on T category and vascular invasion were available for only some patients. Conclusions: Surveillance is a difficult type of study and missing data may compromise the therapeutic program based on prognostic factors.
引用
收藏
页码:1045 / 1049
页数:5
相关论文
共 20 条
[1]  
CULLEN MH, 1994, ADV BIOSCI, V91, P201
[2]   RETROPERITONEAL LYMPHADENECTOMY FOR CLINICAL STAGE-A TESTIS CANCER (1965 TO 1989) - MODIFICATIONS OF TECHNIQUE AND IMPACT ON EJACULATION [J].
DONOHUE, JP ;
THORNHILL, JA ;
FOSTER, RS ;
ROWLAND, RG ;
BIHRLE, R .
JOURNAL OF UROLOGY, 1993, 149 (02) :237-243
[3]  
GERL A, 1994, P AM SOC CLIN ONCOL, V13, P229
[4]   TREATMENT DECISION FOR STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS BASED ON THE RISK FACTOR VASCULAR INVASION [J].
HOELTL, W ;
PONT, J ;
KOSAK, D ;
HONETZ, N ;
MARBERGER, M .
BRITISH JOURNAL OF UROLOGY, 1992, 69 (01) :83-87
[5]   RETROPERITONEAL LYMPHADENECTOMY FOR TESTIS TUMOR WITH NERVE SPARING FOR EJACULATION [J].
JEWETT, MAS ;
KONG, YSP ;
GOLDBERG, SD ;
STURGEON, JFG ;
THOMAS, GM ;
ALISON, RE ;
GOSPODAROWICZ, MK .
JOURNAL OF UROLOGY, 1988, 139 (06) :1220-1224
[6]   PROGNOSTIC FACTORS IN CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - MULTIVARIATE-ANALYSIS OF A PROSPECTIVE MULTICENTER STUDY [J].
KLEPP, O ;
OLSSON, AM ;
HENRIKSON, H ;
AASS, N ;
DAHL, O ;
STENWIG, AE ;
PERSSON, BE ;
CAVALLINSTAHL, E ;
FOSSA, SD ;
WAHLQVIST, L .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :509-518
[7]  
LOWE BA, 1993, UROL CLIN N AM, V20, P75
[8]  
NICHOLS C, 1994, P AN M AM SOC CLIN, V13, P234
[9]  
PECKHAM MJ, 1982, LANCET, V2, P678
[10]   DIFFICULTIES OF A SURVEILLANCE STUDY OMITTING RETROPERITONEAL LYMPHADENECTOMY IN CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS [J].
PIZZOCARO, G ;
ZANONI, F ;
SALVIONI, R ;
MILANI, A ;
PIVA, L ;
PILOTTI, S .
JOURNAL OF UROLOGY, 1987, 138 (06) :1393-1396